Sensitivity to chemotherapy/tyrosine kinase inhibitors of mucinous lepidic adenocarcinoma should be tested in a phase III trial?

  • Auteurs / Authors: Cadranel J, Wislez M, Langlais A, Morin F, Zalcman G
  • Journal / Conference: European Respiratory Journal
  • Année / Year: 2016
  • PMID: 27246084
  • Lien vers la publication: https://www.ncbi.nlm.nih.gov/pubmed/27246084
  • PDF: Sensitivity_to_chemoterapy._Cadranel.ERJ.2016.pdf